- Systematic review and meta-analysis
- Genetics and Metabolism
- Global prevalence of classic phenylketonuria based on Neonatal Screening Program Data: systematic review and meta-analysis
-
Hamid Reza Shoraka, Ali Akbar Haghdoost, Mohammad Reza Baneshi, Zohre Bagherinezhad, Farzaneh Zolala
-
Clin Exp Pediatr. 2020;63(2):34-43. Published online February 6, 2020
-
|
Question: What is the global prevalence of classic phenylketonuria based on Neonatal Screening Program Data?
Finding: The overall worldwide prevalence of the disease is 6.002 per 100,000 neonates. The highest prevalence (38.13) was reported in Turkey, while the lowest (0.3) in Thailand.
Meaning: This difference in the prevalence may be due to differences in the number of consanguineous marriages among the different regions, phenylalanine cutoff points, and sample sizes. |
-
-
|